ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 917

$722K Total Retail Price of All Prescriptions

Rank: 40 out of 917

801 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 801 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 801 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 12,609 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 843 769 1 3
LISINOPRIL 595 537 2 1
OMEPRAZOLE 490 444 3 4
AMLODIPINE BESYLATE 479 451 4 5
SERTRALINE HCL 316 299 5 24
HYDROCODONE-ACETAMINOPHEN 315 285 S3 6 6
METFORMIN HCL 295 269 7 8
SIMVASTATIN 291 265 8 2
HYDROCHLOROTHIAZIDE 289 273 9 9
ATENOLOL 287 259 10 12
TRAZODONE HCL 276 213 11 22
GABAPENTIN 275 257 12 17
LOSARTAN POTASSIUM 274 272 13 13
PRAVASTATIN SODIUM 268 250 14 20
ATORVASTATIN CALCIUM 262 255 15 14
METOPROLOL SUCCINATE 255 236 16 18
FUROSEMIDE 245 218 17 7
ZOLPIDEM TARTRATE 229 204 18 21
CITALOPRAM HBR 227 203 19 15
METOPROLOL TARTRATE 205 199 20 11
WARFARIN SODIUM 188 183 21 10
ALENDRONATE SODIUM 187 162 22 23
FLUTICASONE PROPIONATE 186 161 23 26
POTASSIUM CHLORIDE 182 155 24 16
QUETIAPINE FUMARATE 144 136 25 52
TRIAMTERENE-HCTZ 142 137 26 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 118 27 42
LOVASTATIN 129 129 28 19
PREDNISONE 123 115 29 34
ALLOPURINOL 115 103 30 31
PROAIR HFA 109 85 31 35
DIOVAN 103 91 32 49
PAROXETINE HCL 102 82 33 57
SPIRIVA 100 90 34 45
CRESTOR 98 94 35 30
GLIPIZIDE ER 95 94 36 128
DONEPEZIL HCL 94 94 37 32
NAMENDA 92 92 38 43
OXYBUTYNIN CHLORIDE ER 92 92 38 123
LIPITOR 91 86 40 89
GLIPIZIDE XL 78 67 41 142
RANITIDINE HCL 72 50 42 29
POLYETHYLENE GLYCOL 3350 72 67 42 66
ESTRADIOL 71 52 R 44 102
ADVAIR DISKUS 67 61 45 47
ETODOLAC 66 57 46 182
FLUOXETINE HCL 66 29 46 38
LOSARTAN-HYDROCHLOROTHIAZIDE 65 65 48 62
MIRTAZAPINE 65 65 48 39
DILTIAZEM 24HR ER 64 60 50 177
OXYCODONE-ACETAMINOPHEN 64 47 S2 50 46
PANTOPRAZOLE SODIUM 62 40 52 44
LEVOXYL 60 57 53 142
NORTRIPTYLINE HCL 58 57 54 136
LANTUS 57 57 55 37
DILTIAZEM 24HR CD 57 54 55 95
NEXIUM 57 57 55 60
ENALAPRIL MALEATE 56 52 58 79
BENAZEPRIL HCL 55 55 59 80
SYNTHROID 54 45 60 68
PROPRANOLOL HCL 53 44 61 126
CARBIDOPA-LEVODOPA 53 43 61 86
VENLAFAXINE HCL ER 52 46 63 78
OXYCODONE HCL 50 22 S2 64 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.